
Why the U.S. Is Underestimating COVID Reinfection
Many U.S. states aren’t rigorously tracking or investigating suspected cases of reinfection
Many U.S. states aren’t rigorously tracking or investigating suspected cases of reinfection
It will not be an easy task
Fears about lingering coronavirus are prompting a massive disinfection initiative before the Bidens move in
In 16 states that have released data by race, white residents are being vaccinated at much higher rates—in many cases two to three times higher
California Attorney General Xavier Becerra has never held a position in public health administration, but he has led dozens of lawsuits to protect the Affordable Care Act and health rights...
Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits
Joe Biden won the election, but Senate Republicans could block his attempts to expand the Affordable Care Act
The outcome could have important consequences for Medicaid, abortion access, and legalization of marijuana and other drugs
Voters must decide whether to keep financing the second largest funder of stem cell science in the world
As the Trump administration eyes a speedy replacement, the court will hear a case against the health care law a week after the election
Whether it’s a cough or a sore throat, doctors in areas affected by the recent wildfires must determine whether symptoms are caused by the coronavirus, smoke or even the flu
The test was halted when a participant suffered spinal cord damage, and U.S. scientists launched an investigation
With no clear guidance from the federal government, schools are pursuing a mix of online and in-person classes
Public health experts offer tips for evaluating the risks of visiting public places during the COVID-19 pandemic
Late-stage clinical trials of the first two coronavirus vaccine candidates in the U.S. plan to recruit 60,000 Americans
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials...
The White House told hospitals to report data through a private company system instead of the Centers for Disease Control and Prevention
Experts explain the best time for testing after exposure and how to find test sites
The pandemic has heightened OCD phobias such as fear of germs. Yet some patients say experience with anxiety, and treatment for it, gives them an advantage
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account